nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—Verapamil—CACNA1G—type 1 diabetes mellitus	0.0396	0.625	CrCbGaD
Tofisopam—Verapamil—KCNJ11—type 1 diabetes mellitus	0.0237	0.375	CrCbGaD
Tofisopam—PDE3A—penis—type 1 diabetes mellitus	0.0162	0.553	CbGeAlD
Tofisopam—PDE10A—nephron tubule—type 1 diabetes mellitus	0.00509	0.174	CbGeAlD
Tofisopam—PDE2A—cardiovascular system—type 1 diabetes mellitus	0.00457	0.156	CbGeAlD
Tofisopam—PDE3A—cardiovascular system—type 1 diabetes mellitus	0.0026	0.0889	CbGeAlD
Tofisopam—PDE2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00212	0.00234	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IGF1—type 1 diabetes mellitus	0.0021	0.00232	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.00209	0.0023	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00208	0.00229	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00208	0.00229	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00207	0.00228	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00207	0.00228	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.002	0.0022	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—type 1 diabetes mellitus	0.00199	0.0022	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00196	0.00216	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00191	0.0021	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00189	0.00208	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00188	0.00207	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00185	0.00204	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00184	0.00203	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00182	0.002	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS2—type 1 diabetes mellitus	0.0018	0.00198	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00179	0.00198	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00179	0.00197	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00178	0.00197	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS1—type 1 diabetes mellitus	0.00178	0.00196	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00177	0.00195	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00177	0.00195	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00174	0.00192	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00173	0.00191	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00173	0.0019	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00171	0.00188	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00169	0.00186	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00168	0.00185	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00168	0.00185	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00168	0.00185	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00167	0.00184	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.00166	0.00183	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00166	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00165	0.00182	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00165	0.00182	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00163	0.00179	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00162	0.00179	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00162	0.00179	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL2—type 1 diabetes mellitus	0.00162	0.00178	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VAV1—type 1 diabetes mellitus	0.00162	0.00178	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00161	0.00177	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00161	0.00177	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00161	0.00177	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00161	0.00177	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00161	0.00177	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IGF1—type 1 diabetes mellitus	0.00159	0.00176	CbGpPWpGaD
Tofisopam—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00159	0.00175	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00158	0.00174	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00157	0.00173	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00157	0.00173	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00155	0.00171	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00153	0.00169	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00151	0.00167	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—type 1 diabetes mellitus	0.00151	0.00166	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00151	0.00166	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00149	0.00164	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00147	0.00162	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00147	0.00161	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF2—type 1 diabetes mellitus	0.00146	0.00161	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00144	0.00159	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00143	0.00158	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.0014	0.00154	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00139	0.00154	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00136	0.0015	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00136	0.00149	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00134	0.00148	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00132	0.00146	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00131	0.00145	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.0013	0.00144	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00128	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00127	0.0014	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00127	0.0014	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00127	0.0014	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00126	0.00139	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00126	0.00139	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00125	0.00138	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.00123	0.00136	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00123	0.00135	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00123	0.00135	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2—type 1 diabetes mellitus	0.00122	0.00135	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00122	0.00135	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00122	0.00134	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00122	0.00134	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.0012	0.00132	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00114	0.00126	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00114	0.00126	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00112	0.00124	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00112	0.00123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00111	0.00123	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00111	0.00123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00111	0.00122	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00111	0.00122	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00111	0.00122	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00109	0.0012	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00108	0.00119	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00107	0.00118	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS2—type 1 diabetes mellitus	0.00106	0.00117	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00105	0.00116	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00105	0.00116	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00105	0.00115	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00102	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00102	0.00113	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00102	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00102	0.00112	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00101	0.00112	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000994	0.0011	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000992	0.00109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000986	0.00109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000981	0.00108	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000975	0.00107	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000975	0.00107	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000964	0.00106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000959	0.00106	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000957	0.00105	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000955	0.00105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000953	0.00105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000951	0.00105	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000948	0.00105	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000948	0.00105	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000948	0.00105	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF1—type 1 diabetes mellitus	0.000939	0.00104	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000935	0.00103	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000929	0.00102	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000928	0.00102	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000927	0.00102	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000927	0.00102	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000925	0.00102	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000917	0.00101	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000892	0.000983	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—type 1 diabetes mellitus	0.00089	0.000981	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS3—type 1 diabetes mellitus	0.000852	0.000939	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000845	0.000931	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000842	0.000927	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000823	0.000907	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000819	0.000902	CbGpPWpGaD
Tofisopam—CYP3A4—kidney—type 1 diabetes mellitus	0.000816	0.0279	CbGeAlD
Tofisopam—PDE4A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000812	0.000895	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00081	0.000893	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.0008	0.000882	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.0008	0.000882	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00079	0.00087	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00078	0.00086	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000778	0.000858	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000774	0.000854	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000774	0.000853	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00077	0.000848	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00077	0.000848	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000769	0.000848	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000753	0.00083	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000749	0.000825	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000749	0.000825	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000737	0.000812	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000737	0.000812	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000731	0.000805	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000726	0.000801	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2—type 1 diabetes mellitus	0.000722	0.000796	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000719	0.000792	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000717	0.00079	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000713	0.000786	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000709	0.000782	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000708	0.000781	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000707	0.000779	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000703	0.000775	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000676	0.000745	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000673	0.000741	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000659	0.000726	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000657	0.000724	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000654	0.000721	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000646	0.000712	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000602	0.000664	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000591	0.000652	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000586	0.000646	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00058	0.000639	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000564	0.000622	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000563	0.000621	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000562	0.000619	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000559	0.000616	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000549	0.000605	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000548	0.000604	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000548	0.000604	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000546	0.000602	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000545	0.000601	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.00054	0.000595	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000538	0.000593	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000512	0.000564	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00051	0.000562	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000499	0.00055	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000498	0.000549	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000496	0.000547	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000491	0.000541	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00049	0.00054	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000478	0.000526	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000469	0.000517	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000466	0.000513	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000461	0.000508	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000456	0.000503	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000453	0.0005	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000443	0.000488	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000435	0.00048	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000431	0.000475	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000429	0.000473	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000426	0.000469	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000424	0.000467	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000419	0.000462	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000417	0.00046	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000416	0.000458	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000415	0.000458	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000414	0.000457	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000413	0.000455	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000358	0.000395	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000349	0.000385	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000348	0.000384	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000338	0.000373	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000329	0.000363	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000327	0.000361	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000326	0.000359	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000322	0.000355	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000318	0.000351	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000318	0.00035	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000317	0.000349	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000302	0.000333	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000297	0.000327	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000294	0.000324	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000289	0.000318	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.00028	0.000309	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000263	0.00029	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000252	0.000278	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000252	0.000277	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.00025	0.000276	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000245	0.00027	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000245	0.00027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000244	0.000269	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000244	0.000268	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000228	0.000252	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000212	0.000233	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000206	0.000227	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000192	0.000212	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000187	0.000206	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000181	0.000199	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.000152	0.000168	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000148	0.000163	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000144	0.000159	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000143	0.000158	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000143	0.000157	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.00014	0.000154	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	0.000112	0.000123	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	9.44e-05	0.000104	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	6.27e-05	6.91e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	5.75e-05	6.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	5.5e-05	6.06e-05	CbGpPWpGaD
